Patent Assignment
Reel/Frame 018621/0312
Change of Name
Recorded: 2006-11-20
Pages: 3
Assignor
JONES PHARMA INCORPORATED
Executed: 2004-12-01
Assignee
KING PHARMACEUTICALS RESEARCH & DEVELOPMENT, INC.
CENTREGREEN TWO, SUITE 300, 4000 CENTREGREEN WAY, CARY, NORTH CAROLINA, 27513
Covered Property
(1)
Methods of Modifying the Bioavailability of Metaxalone
Patent:
7,714,006 →
Application:
11/182,661 →
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Agreement
Dec 30, 2008
From: KING PHARMACEUTICALS RESEARCH & DEVELOPMENT, INC.
To: CREDIT SUISSE, AS AGENT
Reel/Frame 022034/0870 →
Release of Security Interest
May 11, 2010
From: KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.
To: CREDIT SUISSE AG
Reel/Frame 024369/0022 →
Security Agreement
May 13, 2010
From: KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.
To: CREDIT SUISSE AG
Reel/Frame 025703/0628 →
Release of Security Interest
Feb 3, 2011
From: CREDIT SUISSE AG
To: KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.
Reel/Frame 025738/0132 →
Correspondents Address Correction
Dec 15, 2016
From: KING PHARMACEUTICALS RESEARCH & DEVELOPMENT, INC.
To: KING PHARMACEUTICALS RESEARCH & DEVELOPMENT, INC.
Reel/Frame 040940/0494 →